Trustworthy Artificial Intelligence employed by Clarivate to revolutionize your realm
In the ever-evolving world of technology, Clarivate is making significant strides in integrating Artificial Intelligence (AI) into their business operations.
One of the key areas where AI is being utilised is in the scrutiny of academic journals listed within the Web of ScienceTM. AI helps in identifying outlier journals and ensuring trust in all indexed publications. Trained machine learning algorithms flag suspect journals to in-house editors for a thorough analysis, maintaining the integrity of the database.
Clarivate's CompuMarkTM Naming Tool is another example of AI integration. This tool is trained on US, EU, and Pharma In-Use databases and uses generative AI to automate the process of brainstorming new brand names. It also analyses potential brand names for usability and checks them against existing domain names and social media handles, streamlining the branding process.
The CompuMarkTM Naming Tool isn't the only area where AI is making a difference. Clarivate is also leveraging machine learning to generate predictors of future success in clinical trials, regulatory approvals, and M&A valuations within CortellisTM. The Clarivate research group, Trial Insights, uses machine learning to predict clinical trial progression, regulatory approvals, and even valuations for M&A candidates.
Clarivate's extensive collection of billions of proprietary best-in-class data assets are expertly curated and interconnected, providing a robust foundation for AI applications. This data is protected to ensure the privacy and security of customers and partners.
Clarivate's Data Science team has been implementing AI across their portfolio for decades. They have company-wide guidelines for the use of generative AI applications or tools, and an internal approvals process is in place to ensure checks and balances before using generative AI with any of their products or services.
AI is also being used to enhance the quality of integrated public and proprietary content and insights. This includes the development of new AI tools, such as those aimed at making a positive difference in the lives of individual patients in the search for an effective treatment of a rare disease that causes blindness.
It's important to note that these guidelines are subject to constant review and evolution as AI technology changes. Clarivate also has strict controls in place to prevent any third party from using their content and products within their use of generative AI.
In conclusion, Clarivate's commitment to AI is evident in their various applications across their business. From academic journal scrutiny to brand name generation and predictive analytics, AI is helping Clarivate to innovate and deliver value to their customers.
Read also:
- EPA Administrator Zeldin travels to Iowa, reveals fresh EPA DEF guidelines, attends State Fair, commemorates One Big Beautiful Bill
- Derrick Xiong, one of the pioneers behind the drone company EHang
- Latest Update in Autonomous Vehicle Sector featuring Applied Intuition, Hesai, Plus, Tesla, Pony.ai, and Wayve
- Challenges impeding the implementation of AI, as cited by Chief Information Security Officers, along with potential solutions
